News
News Center
2020-02-25
On February 21, the Joint Prevention and Control Mechanism of the State Council for the COVID-19 Epidemic held a press conference. At the briefing, Vice Minister of Science and Technology Xu Nanping announced that four critically ill COVID-19 patients have now been discharged from the hospital after receiving stem-cell therapy, and clinical trials will soon be expanded to further evaluate its effectiveness.
+
2020-01-28
At Zhejiang University First Hospital, we’ve been using a new approach called stem cell therapy in the treatment of H7N9 avian influenza. Early findings suggest that stem cells show promising results in addressing lung infections and pulmonary fibrosis in avian flu patients. As a result, the hospital’s ethics committee has already approved this innovative treatment, and we’re now preparing to apply it to severe cases of the novel coronavirus.
+
2019-09-23
China's 9th Annual Stem Cell Conference Held in Tianjin
Stem Cell Research and Translation: Ready to Revolutionize—Jiuzhitang Maker is committed to becoming China's pioneer and leader in stem-cell-based pharmaceuticals!
+
2019-09-12
During the forum, Li Zhenguo, President of Jiuzhitang Group and Chairman of Jiuzhitang Co., Ltd., along with Milan from Kazakhstan’s ALTACO Company, jointly unveiled the Jiuzhitang-ALTACO International Medical Center, witnessed by attendees of the event. This marks the official establishment of the center within the China-Kazakhstan Khorgos Border Cooperation Center.
+
2019-09-12
Economic Daily – China Economic Net, Khorgos, September 7: On September 7, the China-Kazakhstan Medical and Healthcare Industry Summit Forum was held. Li Zhenguo, Chairman of Jiuzhitang Co., Ltd., emphasized at the Belt and Road Initiative Summit on Traditional Medicine and Regenerative Medicine that China should fully leverage the advantages of traditional Chinese medicine to foster cooperation in the medical and healthcare sectors along the Belt and Road countries. At the same time, by integrating traditional Chinese medicine with Western medical approaches, we can draw on cutting-edge global medical advancements, ultimately providing comprehensive, life-cycle health management solutions for people living along the Belt and Road routes.
+
2019-08-21
What precautions should be taken when undergoing stem cell therapy? After undergoing hematopoietic stem cell bone marrow transplantation, will the DNA of the transplanted individual’s blood match that of the recipient? Can mesenchymal stem cells be produced in bulk?
+
2019-08-20
In 2018, Jiuzhitang turned its focus toward the cutting-edge international field of bio-cellular technology by establishing Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd. As the sole Chinese partner for stem cell technologies developed by the U.S.-based company Stemedica, the company began pursuing business opportunities related to stem cell research. Meanwhile, Jiuzhitang signed a "Joint Construction Agreement for a Stem Cell Clinical Research Base" with Beijing Tiantan Hospital, Affiliated to Capital Medical University, jointly establishing the "Jiuzhitang Maker Stem Cell Clinical Research Base at Beijing Tiantan Hospital," which has now been completed.
+
2019-07-30
Jiuzhitang is making strides in the stem-cell field, with promising prospects for future growth.
As a national key Chinese medicine enterprise, a national key high-tech enterprise, a national pilot innovative company, and the leading enterprise in Hunan Province’s pharmaceutical industry, Jiuzhitang boasts a rich historical legacy, a strong brand image, and significant industry influence. Now, with its strategic expansion into the stem-cell field, we believe that Jiuzhitang’s future growth prospects are indeed promising.
+
2019-07-05
Biopharmaceuticals are a hot area in 21st-century pharmaceutical research, and stem cells, in particular, are at the cutting edge of this exciting field with incredibly promising prospects.
+
Here is the title—h1 placeholder text
Copyright © Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd.
Powered by: 300.cn SEO | Privacy Policy